2 unknown, 1 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Broncus Technologies: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the LungPoint Virtual Bronchoscopic Navigation (VBN) System LungPoint Virtual Bronchoscopic Navigation (computer-assisted image-guided bronchoscopic navigation) - Lung Neoplasm | Unknown | Broncus Technologies | 60 | 2009-07-01 | 2010-02-12 | |
| EASE Trial: Exhale Airway Stents for Emphysema Exhale® Drug-Eluting Stent, Sham control - Emphysema | Phase 3 | Unknown | Broncus Technologies | 450 | 2006-05-01 | 2011-01-12 |
| Exhale (R) Stent for Emphysema Exhale Drug-Eluting Stent - Emphysema | Phase 2 / Phase 3 | Completed | Broncus Technologies | 60 | 2004-07-01 | 2008-01-23 |
Emphysema (2) · Pulmonary Disease, Chronic Obstructive (2) · Lung Neoplasms (1) · Lymphadenopathy (1)
Germany (3) · Australia (2) · Brazil (2) · Austria (1) · Canada (1) · Ireland (1) · Netherlands (1) · Spain (1) · United Kingdom (1) · United States (1)
Felix Herth, MD, PhD, FCCP (1) · Gerhard W. Sybrecht, Prof. Dr. med. (1) · Gregory I. Snell, MD (1) · Joel D. Cooper, MD, FACS, FRCS (1)